Phase 1 study: New medicine extends terminally-ill cancer patients' lives
by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague
Updated on: February 18,2024
12

Phase 1 study: New medicine extends terminally-ill cancer patients' lives
by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague
Updated on:February 18,2024
12
